Ignite Creation Date:
2024-06-16 @ 11:52 AM
Last Modification Date:
2024-10-26 @ 3:31 PM
Study NCT ID:
NCT06451692
Status:
RECRUITING
Last Update Posted:
2024-06-11
First Post:
2024-05-28
Brief Title:
Prioritising Patient Medication Review Hospitals Reaching Out
Sponsor:
University of Southern Denmark
Organization:
University of Southern Denmark
Study Overview
Official Title:
Prioritising Patient Medication Review Hospitals Reaching Out PriPMed
Status:
RECRUITING
Status Verified Date:
2024-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
PriPMed
Brief Summary:
To examine the effect of a cross-sectoral medication review intervention to admitted multi-morbid polypharmacy patients aged 65 at SHS in two settings an acute admission unit typical admission time 48 hours and a medical outpatient setting patients routinely visits for follow-up diagnosis or treatment but do require a bed or overnight care
Detailed Description:
Lack of medication treatment coordination among especially multi-morbid patients results in suboptimal medication treatment adverse effects increased use of resources hospital admissions and premature death Further an aging population is a challenge to healthcare systems worldwide as older adults are vulnerable to non-communicable diseases and multi-morbidity The age distribution varies across Denmark creating demographic inequality with a higher proportion of elderly in several municipalities in Southern Jutland and on a national level the population aged 70 already accounts for more than a third of all hospital days
As the population ages the concept of frailty becomes increasing in the provision of health care to an ageing population and the Clinical Frailty Scale CFS can be used as a judgement-based frailty tool to evaluate specific domains including comorbidity function and cognition to generate a frailty score In addition an attempt to detect patients at high risk of medication errors is the Medicine Risk Score MERIS where acutely admitted patients are allocated into low and high risk of potential ADEs by predefined detection limits Further These components will be used to determine
In addition an understudied patient group within polypharmacy and PIPs are patients with dementia creating inequality among patient groups The use of polypharmacy and Potential Inappropriate Prescribing are widespread in this patient group and dementia is well-known to have a negative effect on overall mortality which demonstrates the need for interventions to improve medication treatment in people with dementia Intervention studies have examined the effects of pharmacist-led medication reviews in different hospital settings with various outcomes but no exact model for prioritising patient medication review exists Thus there is a need to identify patients who will benefit most from a medication review in terms of outcomes such as readmission emergency department and general practitioner contacts The aim of this project is to examine the effect of a cross-sectoral medication review between a clinical pharmacist and a medical specialist in coordination with the General Practitioner GP including patients from Hospital Sønderjylland University Hospital of Southern Denmark SHS
As the population ages the concept of frailty becomes increasing in the provision of health care to an ageing population and the Clinical Frailty Scale CFS can be used as a judgement-based frailty tool to evaluate specific domains including comorbidity function and cognition to generate a frailty score In addition an attempt to detect patients at high risk of medication errors is the Medicine Risk Score MERIS where acutely admitted patients are allocated into low and high risk of potential ADEs by predefined detection limits Further These components will be used to determine
In addition an understudied patient group within polypharmacy and PIPs are patients with dementia creating inequality among patient groups The use of polypharmacy and Potential Inappropriate Prescribing are widespread in this patient group and dementia is well-known to have a negative effect on overall mortality which demonstrates the need for interventions to improve medication treatment in people with dementia Intervention studies have examined the effects of pharmacist-led medication reviews in different hospital settings with various outcomes but no exact model for prioritising patient medication review exists Thus there is a need to identify patients who will benefit most from a medication review in terms of outcomes such as readmission emergency department and general practitioner contacts The aim of this project is to examine the effect of a cross-sectoral medication review between a clinical pharmacist and a medical specialist in coordination with the General Practitioner GP including patients from Hospital Sønderjylland University Hospital of Southern Denmark SHS
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None